US › Healthcare

Lite Strategy, Inc. (LITS)

US · Healthcare · Biotechnology

$0.94-3.76%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$0
Net profit
$-23.7M
Profit YoY
-820.9%
EPS
$-0.66

Key statistics

Market cap
$32.8M
Forward P/E
4.6
P/B
0.58
Book value
$1.62
EPS (TTM)
$-2.08
52-week high
$5.55
52-week low
$0.69
50-day MA
$0.93
200-day MA
$1.29
Beta
0.05

Shareholding

Insiders
11.96%
Institutions
17.32%

Largest institutional holders

FundStake
Renaissance Technologies Corp5.47%
Vanguard Capital Management, LLC3.27%
Citadel Advisors Llc2.29%
Two Sigma Investments LLC1.93%
Geode Capital Management, LLC1.26%
Marshall Wace Asset Management Ltd1.05%
Vanguard Fiduciary Trust Co0.61%
BlackRock Inc0.50%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Lite Strategy, Inc. — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.